BDTX Black Diamond Therapeutics, Inc.
Nasdaq · SEC CIK 1701541 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 139 since 2021-08-11, latest 2026-09-21 17:45
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Raman Prakash | Dir | — | — |
| Behbahani Ali | Dir | — | — |
Transactions 80
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-21 17:45 | 2026-09-18 | BDTX | Behbahani Ali | Dir | A - Grant | $1.93 | +7,707 | 110.2K | +8% | +$14.9K | |
| 2026-09-21 17:30 | 2026-09-18 | BDTX | Raman Prakash | Dir | A - Grant | $1.93 | +6,801 | 51.8K | +15% | +$13.1K | |
| 2026-06-22 16:19 | 2026-06-19 | BDTX | Behbahani Ali | Dir | A - Grant | $1.66 | +8,961 | 102.5K | +10% | +$14.9K | |
| 2026-06-22 16:06 | 2026-06-19 | BDTX | Raman Prakash | Dir | A - Grant | $1.66 | +7,907 | 45.0K | +21% | +$13.1K | |
| 2026-03-20 | 2026-03-20 | BDTX | Behbahani Ali | Dir | A - Grant | $2.15 | +6,919 | 93.6K | +8% | +$14.9K | |
| 2026-03-20 | 2026-03-20 | BDTX | Raman Prakash | Dir | A - Grant | $2.15 | +6,105 | 37.1K | +20% | +$13.1K | |
| 2025-12-15 | 2025-12-12 | BDTX | Behbahani Ali | Dir | A - Grant | $2.76 | +5,208 | 86.6K | +6% | +$14.4K | |
| 2025-12-15 | 2025-12-12 | BDTX | Raman Prakash | Dir | A - Grant | $2.76 | +4,665 | 31.0K | +18% | +$12.9K | |
| 2025-09-22 | 2025-09-19 | BDTX | Behbahani Ali | Dir | A - Grant | $3.35 | +4,291 | 81.4K | +6% | +$14.4K | |
| 2025-09-22 | 2025-09-19 | BDTX | Raman Prakash | Dir | A - Grant | $3.35 | +3,843 | 26.4K | +17% | +$12.9K | |
| 2025-06-20 | 2025-06-20 | BDTX | Behbahani Ali | Dir | A - Grant | $2.33 | +6,170 | 77.2K | +9% | +$14.4K | |
| 2025-06-20 | 2025-06-20 | BDTX | Raman Prakash | Dir | A - Grant | $2.33 | +5,526 | 22.5K | +33% | +$12.9K | |
| 2025-03-21 | 2025-03-21 | BDTX | Behbahani Ali | Dir | A - Grant | $1.88 | +7,646 | 71.0K | +12% | +$14.4K | |
| 2025-03-21 | 2025-03-21 | BDTX | Raman Prakash | Dir | A - Grant | $1.88 | +6,848 | 17.0K | +68% | +$12.9K | |
| M | 2025-03-20 | 2025-03-19 | BDTX | BIOTECH GROWTH N V | 10% | S - Sale | $2.07 | -5.78M | 3.23M | -64% | -$12.00M |
| D | 2025-01-31 | 2025-01-30 | BDTX | Buck Elizabeth | CSO | A - Grant | $0.00 | +75.0K | 170.2K | +79% | $0 |
| D | 2025-01-31 | 2025-01-30 | BDTX | Yurasov Sergey | Chief MEDICAL Off | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 |
| D | 2025-01-31 | 2025-01-30 | BDTX | Velleca Mark A. | Pres, CEO, Dir | A - Grant | $0.00 | +75.0K | 121.5K | +161% | $0 |
| D | 2025-01-31 | 2025-01-30 | BDTX | Hatzis-Schoch Brent | SEE REMARKS | A - Grant | $0.00 | +75.0K | 83.4K | +893% | $0 |
| D | 2025-01-31 | 2025-01-30 | BDTX | Jones Erika | SEE REMARKS | A - Grant | $0.00 | +75.0K | 85.2K | +739% | $0 |
| 2024-12-16 | 2024-12-13 | BDTX | Behbahani Ali | Dir | A - Grant | $2.50 | +5,750 | 63.3K | +10% | +$14.4K | |
| 2024-12-16 | 2024-12-13 | BDTX | Raman Prakash | Dir | A - Grant | $2.50 | +5,150 | 10.1K | +103% | +$12.9K | |
| 2024-12-16 | 2024-12-13 | BDTX | Campbell Shannon | Dir | A - Grant | $2.50 | +4,500 | 8,865 | +103% | +$11.2K | |
| 2024-09-20 | 2024-09-20 | BDTX | Behbahani Ali | Dir | A - Grant | $4.78 | +3,007 | 57.6K | +6% | +$14.4K | |
| 2024-09-20 | 2024-09-20 | BDTX | Raman Prakash | Dir | A - Grant | $4.78 | +2,694 | 4,995 | +117% | +$12.9K | |
| 2024-09-20 | 2024-09-20 | BDTX | Campbell Shannon | Dir | A - Grant | $4.78 | +2,354 | 4,365 | +117% | +$11.3K | |
| 2024-08-30 | 2024-08-28 | BDTX | Versant Voyageurs I Parallel, L.P. | 10% | S - Sale | $6.32 | -221.6K | 3.73M | -6% | -$1.40M | |
| 2024-06-21 | 2024-06-21 | BDTX | Raman Prakash | Dir | A - Grant | $4.98 | +2,301 | 2,301 | New | +$11.5K | |
| 2024-06-21 | 2024-06-21 | BDTX | Campbell Shannon | Dir | A - Grant | $4.98 | +2,011 | 2,011 | New | +$10.0K | |
| 2024-06-21 | 2024-06-21 | BDTX | Behbahani Ali | Dir | A - Grant | $4.98 | +2,887 | 54.6K | +6% | +$14.4K | |
| 2024-04-03 | 2024-03-15 | BDTX | DIXON WENDY L | Dir | A - Grant | $4.54 | +3,253 | 38.1K | +9% | +$14.8K | |
| 2024-04-03 | 2024-03-15 | BDTX | Behbahani Ali | Dir | A - Grant | $4.54 | +3,166 | 51.7K | +7% | +$14.4K | |
| 2023-12-15 | 2023-12-15 | BDTX | Behbahani Ali | Dir | A - Grant | $2.73 | +4,455 | 48.5K | +10% | +$12.2K | |
| 2023-12-15 | 2023-12-15 | BDTX | DIXON WENDY L | Dir | A - Grant | $2.73 | +4,043 | 34.8K | +13% | +$11.0K | |
| 2023-10-19 | 2023-10-17 | BDTX | BIOTECH GROWTH N V | 10% | P - Purchase | $2.34 | +400.0K | 8.52M | +5% | +$936.0K | |
| D | 2023-09-18 | 2023-09-15 | BDTX | Velleca Mark A. | Pres, CEO, Dir | A - Grant | $3.60 | +5,208 | 46.5K | +13% | +$18.7K |
| 2023-09-18 | 2023-09-15 | BDTX | Behbahani Ali | Dir | A - Grant | $3.60 | +3,299 | 44.1K | +8% | +$11.9K | |
| 2023-09-18 | 2023-09-15 | BDTX | DIXON WENDY L | Dir | A - Grant | $3.60 | +2,986 | 30.8K | +11% | +$10.7K | |
| I | 2023-07-07 | 2023-07-05 | BDTX | RA CAPITAL MANAGEMENT, L.P. | Dir | P - Purchase | $5.00 | +935.9K | 3.21M | +41% | +$4.68M |
| I | 2023-07-06 | 2023-07-05 | BDTX | Behbahani Ali | Dir | P - Purchase | $5.00 | +1.00M | 4.45M | +29% | +$5.00M |
| 2023-07-03 | 2023-06-30 | BDTX | BB BIOTECH AG | 10% | P - Purchase | $5.00 | +1.00M | 8.12M | +14% | +$5.00M | |
| 2023-06-29 | 2023-06-27 | BDTX | BIOTECH GROWTH N V | 10% | P - Purchase | $5.49 | +1.74M | 7.12M | +32% | +$9.55M | |
| 2023-06-28 | 2023-06-27 | BDTX | Epstein David M. | SEE REMARKS, Dir | S - Sale | $6.70 | -25.0K | 671.4K | -4% | -$167.5K | |
| 2023-06-16 | 2023-06-16 | BDTX | DIXON WENDY L | Dir | A - Grant | $2.10 | +5,119 | 27.8K | +23% | +$10.7K | |
| 2023-06-16 | 2023-06-16 | BDTX | Behbahani Ali | Dir | A - Grant | $2.10 | +5,655 | 40.8K | +16% | +$11.9K | |
| 2023-06-16 | 2023-06-16 | BDTX | Velleca Mark A. | Dir | A - Grant | $2.10 | +8,929 | 41.3K | +28% | +$18.8K | |
| 2023-03-20 | 2023-03-16 | BDTX | Behbahani Ali | Dir | A - Grant | $1.67 | +7,111 | 35.1K | +25% | +$11.9K | |
| 2023-03-20 | 2023-03-16 | BDTX | DIXON WENDY L | Dir | A - Grant | $1.67 | +6,437 | 22.7K | +40% | +$10.7K | |
| 2023-03-20 | 2023-03-16 | BDTX | Velleca Mark A. | Dir | A - Grant | $1.67 | +11.2K | 32.4K | +53% | +$18.8K | |
| D | 2023-02-15 | 2023-02-13 | BDTX | Jones Erika | SEE REMARKS | A - Grant | $0.00 | +5,075 | 10.2K | +100% | $0 |
| M | 2022-12-23 | 2022-12-21+ | BDTX | Ni Fang | SEE REMARKS | P - Purchase | $1.28 | +56.4K | 89.0K | +173% | +$72.3K |
| 2022-12-19 | 2022-12-16 | BDTX | INGRAM ROBERT ALEXANDER | FORMER Dir | A - Grant | $1.50 | +9,375 | 42.9K | +28% | +$14.1K | |
| 2022-12-19 | 2022-12-16 | BDTX | Velleca Mark A. | Dir | A - Grant | $1.50 | +8,424 | 21.2K | +66% | +$12.6K | |
| 2022-12-19 | 2022-12-16 | BDTX | Behbahani Ali | Dir | A - Grant | $1.50 | +7,917 | 28.0K | +39% | +$11.9K | |
| 2022-12-19 | 2022-12-16 | BDTX | DIXON WENDY L | Dir | A - Grant | $1.50 | +7,167 | 16.2K | +79% | +$10.8K | |
| 2022-11-02 | 2022-10-31 | BDTX | BIOTECH GROWTH N V | 10% | P - Purchase | $2.25 | +99.8K | 5.38M | +2% | +$224.6K | |
| M | 2022-10-31 | 2022-10-27+ | BDTX | BB BIOTECH AG | 10% | P - Purchase | $2.02 | +364.7K | 5.28M | +7% | +$735.5K |
| 2022-10-25 | 2022-10-21 | BDTX | BB BIOTECH AG | 10% | P - Purchase | $1.51 | +87.8K | 4.91M | +2% | +$132.7K | |
| M | 2022-10-21 | 2022-10-19+ | BDTX | BB BIOTECH AG | 10% | P - Purchase | $1.36 | +131.4K | 4.83M | +3% | +$178.9K |
| 2022-09-19 | 2022-09-16 | BDTX | DIXON WENDY L | Dir | A - Grant | $2.62 | +4,103 | 9,049 | +83% | +$10.7K | |
| 2022-09-19 | 2022-09-16 | BDTX | INGRAM ROBERT ALEXANDER | Dir | A - Grant | $2.62 | +6,584 | 33.5K | +24% | +$17.3K | |
| 2022-09-19 | 2022-09-16 | BDTX | Velleca Mark A. | Dir | A - Grant | $2.62 | +4,294 | 12.7K | +51% | +$11.3K | |
| 2022-09-19 | 2022-09-16 | BDTX | Behbahani Ali | Dir | A - Grant | $2.62 | +4,532 | 20.1K | +29% | +$11.9K | |
| 2022-06-30 | 2022-06-29 | BDTX | Ni Fang | SEE REMARKS | P - Purchase | $2.44 | +25.0K | 69.0K | +57% | +$61.0K | |
| A | 2022-06-30 | 2022-06-17 | BDTX | DIXON WENDY L | Dir | A - Grant | $2.03 | +4,946 | 4,946 | New | +$10.0K |
| 2022-06-17 | 2022-06-17 | BDTX | Velleca Mark A. | Dir | A - Grant | $2.03 | +5,542 | 8,439 | +191% | +$11.3K | |
| 2022-06-17 | 2022-06-17 | BDTX | Behbahani Ali | Dir | A - Grant | $2.03 | +5,850 | 15.6K | +60% | +$11.9K | |
| 2022-06-17 | 2022-06-17 | BDTX | DIXON WENDY L | Dir | A - Grant | $2.03 | +4,060 | 4,060 | New | +$8,242 | |
| 2022-06-17 | 2022-06-17 | BDTX | INGRAM ROBERT ALEXANDER | Dir | A - Grant | $2.03 | +8,498 | 26.9K | +46% | +$17.3K | |
| M | 2022-04-29 | 2022-04-27+ | BDTX | BIOTECH GROWTH N V | 10% | P - Purchase | $2.60 | +405.7K | 4.44M | +10% | +$1.06M |
| M | 2022-04-20 | 2022-04-18+ | BDTX | BIOTECH GROWTH N V | 10% | P - Purchase | $3.27 | +300.0K | 4.29M | +8% | +$979.5K |
| M | 2022-04-14 | 2022-04-12+ | BDTX | BIOTECH GROWTH N V | 10% | P - Purchase | $3.48 | +252.6K | 3.89M | +7% | +$879.1K |
| 2022-03-18 | 2022-03-18 | BDTX | Behbahani Ali | Dir | A - Grant | $3.02 | +4,346 | 9,705 | +81% | +$13.1K | |
| 2022-03-18 | 2022-03-18 | BDTX | Velleca Mark A. | Dir | A - Grant | $3.02 | +2,897 | 2,897 | New | +$8,749 | |
| 2022-03-18 | 2022-03-18 | BDTX | INGRAM ROBERT ALEXANDER | Dir | A - Grant | $3.02 | +5,795 | 18.4K | +46% | +$17.5K | |
| D | 2022-02-17 | 2022-02-15 | BDTX | Jones Erika | SEE REMARKS | A - Grant | $0.00 | +5,075 | 5,075 | New | $0 |
| 2021-12-17 | 2021-12-17 | BDTX | Behbahani Ali | Dir | A - Grant | $5.31 | +2,472 | 5,359 | +86% | +$13.1K | |
| 2021-12-17 | 2021-12-17 | BDTX | INGRAM ROBERT ALEXANDER | Dir | A - Grant | $5.31 | +3,296 | 12.6K | +35% | +$17.5K | |
| 2021-09-23 | 2021-09-17 | BDTX | INGRAM ROBERT ALEXANDER | Dir | A - Grant | $9.90 | +1,869 | 9,306 | +25% | +$18.5K | |
| 2021-09-23 | 2021-09-17 | BDTX | Behbahani Ali | Dir | A - Grant | $9.90 | +1,326 | 2,887 | +85% | +$13.1K |
Purchase Sale Sale after option exercise All abbreviations